Atypical preeclampsia without underlying disease and elevated sFlt-1/PlGF ratio

J Obstet Gynaecol Res. 2022 Feb;48(2):471-476. doi: 10.1111/jog.15117. Epub 2021 Dec 1.

Abstract

Atypical preeclampsia before 20 weeks of gestation without an underlying disease is very rare; however, the soluble Fms-like tyrosine kinase 1/placental growth factor (sFlt-1/PlGF) ratios remain unknown. Four pregnant women with no underlying disease, except for a history of childhood IgA vasculitis, developed preeclampsia at 13, 14, 17, and 18 weeks of gestation with sFlt-1/PlGF ratios of 1589, 1183, 500, and 1460 pg/mL, respectively. Their pregnancies were terminated, and they delivered within 2 weeks. All previously abnormal clinical findings normalized within 3 months. The sFlt-1/PlGF ratios were elevated in the four patients with atypical preeclampsia without underlying disease before 20 weeks of gestation. A high sFlt-1/PlGF ratio may be indicative of preeclampsia when no underlying disease is present in pregnancies of less than 20 weeks of gestation.

Keywords: atypical preeclampsia; placental growth factor; preeclampsia; pregnancy; soluble fms-like tyrosine kinase 1.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers
  • Female
  • Humans
  • Placenta Growth Factor
  • Pre-Eclampsia* / diagnosis
  • Pregnancy
  • Vascular Endothelial Growth Factor Receptor-1

Substances

  • Biomarkers
  • Placenta Growth Factor
  • Vascular Endothelial Growth Factor Receptor-1